Angiotensin-converting enzyme
| GO Term | Evidence Code | Reference |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| angiotensin-mediated drinking behavior | ||
| proteolysis | ||
| ceramide biosynthetic process |
|
|
| negative regulation of smooth muscle cell proliferation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| obsolete extracellular space |
|
|
| cytoplasm | ||
| cilium | ||
| cell surface | ||
| brush border membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| virus receptor activity | ||
| endopeptidase activity | ||
| carboxypeptidase activity | ||
| metallopeptidase activity | ||
| peptidyl-dipeptidase activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 53 |
|
|
||
| 536 |
|
|
||
| 546 |
|
|
||
| 578 |
|
|
||
| 660 |
|
|
||
| 690 |
|
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080600 | COVID-19 | |
| DOID:6000 | congestive heart failure |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026